NRAS c.176_178del ;(p.A59del)

Variant ID: 1-115256532-CCAG-C

NM_002524.4(NRAS):c.176_178del;(p.A59del)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.

Nature Communications
Rosen, Ezra Y EY; Won, Helen H HH; Zheng, Youyun Y; Cocco, Emiliano E; Selcuklu, Duygu D; Gong, Yixiao Y; Friedman, Noah D ND; de Bruijn, Ino I; Sumer, Onur O; Bielski, Craig M CM; Savin, Casey C; Bourque, Caitlin C; Falcon, Christina C; Clarke, Nikeysha N; Jing, Xiaohong X; Meng, Fanli F; Zimel, Catherine C; Shifman, Sophie S; Kittane, Srushti S; Wu, Fan F; Ladanyi, Marc M; Ebata, Kevin K; Kherani, Jennifer J; Brandhuber, Barbara J BJ; Fagin, James J; Sherman, Eric J EJ; Rekhtman, Natasha N; Berger, Michael F MF; Scaltriti, Maurizio M; Hyman, David M DM; Taylor, Barry S BS; Drilon, Alexander A
Publication Date: 2022-03-18

Variant appearance in text: NRAS: A59del
PubMed Link: 35304457
Variant Present in the following documents:
  • 41467_2022_Article_28848.pdf
View BVdb publication page